Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard H Hunt

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Gastroenterology Clinics of North America|October 19, 2010
Clinical pharmacology of gastrointestinal and liver disease. PrefaceRichard H Hunt
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 8, 2003
Helicobacter pylori twenty years onRichard H Hunt
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 29, 2003
Motion--Cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs are as safe as placebo for the stomach: arguments for the motionRichard H Hunt
Journal of Clinical Gastroenterology|August 20, 2002
Evolving concepts in the pathophysiology of functional gastrointestinal disorderRichard H Hunt
The American Journal of Medicine|October 14, 2004
Will eradication of Helicobacter pylori infection influence the risk of gastric cancer?Richard H Hunt
Current Pharmaceutical Design|August 21, 2007
Global gastrointestinal safety profile of etoricoxib and lumiracoxibYuhong Yuan, Richard H Hunt
Inflammopharmacology|March 24, 2004
Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?Yuhong Yuan, Richard H Hunt
Clinical and Translational Gastroenterology|October 30, 2015
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?Richard H Hunt, Carmelo Scarpignato
Gastroenterology Clinics of North America|November 26, 2008
Medical management of gastroesophageal reflux diseaseChangcheng Wang, Richard H Hunt
Alimentary Pharmacology & Therapeutics|October 9, 2019
Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the blockCarmelo Scarpignato, Richard H Hunt
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Gastroenterology Clinics of North America|October 19, 2010
Clinical pharmacology of gastrointestinal and liver disease. PrefaceRichard H Hunt
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 8, 2003
Helicobacter pylori twenty years onRichard H Hunt
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 29, 2003
Motion--Cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs are as safe as placebo for the stomach: arguments for the motionRichard H Hunt
Journal of Clinical Gastroenterology|August 20, 2002
Evolving concepts in the pathophysiology of functional gastrointestinal disorderRichard H Hunt
The American Journal of Medicine|October 14, 2004
Will eradication of Helicobacter pylori infection influence the risk of gastric cancer?Richard H Hunt
Current Pharmaceutical Design|August 21, 2007
Global gastrointestinal safety profile of etoricoxib and lumiracoxibYuhong Yuan, Richard H Hunt
Inflammopharmacology|March 24, 2004
Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?Yuhong Yuan, Richard H Hunt
Clinical and Translational Gastroenterology|October 30, 2015
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?Richard H Hunt, Carmelo Scarpignato
Gastroenterology Clinics of North America|November 26, 2008
Medical management of gastroesophageal reflux diseaseChangcheng Wang, Richard H Hunt
Alimentary Pharmacology & Therapeutics|October 9, 2019
Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the blockCarmelo Scarpignato, Richard H Hunt
Pageof 12